This speculation is in accordance with literature data showing the protective effect of DNMT inhibitors (e.g., RG108 [48], 5-azacytidine [49]) and HAT inhibitors (e.g., curcumin [56], L003 and C646 [57]) in heart failure or cardiac remodeling. This evidence concerns the gene DNMT1 and heart failure.